A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Small Cell Lung Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Beijing Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Rong Yu, M.D.)
    Contact: Principal Investigator (Rong Yu, M.D.)
  • The First Medical Center of Chinese PLA General Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yi Hu, M.D.)
    Contact: Principal Investigator (Yi Hu, M.D.)
  • Beijing Chest Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Gen Lin, M.D.)
    Contact: Principal Investigator (Gen Lin, M.D.)
  • Beijing Luhe Hospital, Capital Medical University, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Dong Yan, M.D.)
    Contact: Principal Investigator (Dong Yan, M.D.)
  • Cancer Hospital, Chinese Academy of Medical Sciences, Beijin, Beijin, China

    Contact: Study coordinator (Zhijie Wang, M.D.)
    Contact: Principal Investigator (Zhijie Wang, M.D.)
  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Ge Luo, M.D.)
    Contact: Principal Investigator (Ge Luo, M.D.)
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Haipeng Xu, M.D.)
    Contact: Principal Investigator (Haipeng Xu, M.D.)
  • PLA No. 900 Hospital of the Joint Support Force, Fuzhou, Fujian, China

    Contact: Study coordinator (Zongyang Yu, M.D.)
    Contact: Principal Investigator (Zongyang Yu, M.D.)
  • Longyan First Hospital, Longyan, Fujian, China

    Contact: Study coordinator (Chunyue Wang, M.D.)
    Contact: Principal Investigator (Chunyue Wang, M.D.)
  • Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, Fujian, China

    Contact: Study coordinator (Li Lin, M.D.)
    Contact: Principal Investigator (Li Lin, M.D.)
  • Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China

    Contact: Study coordinator (Shihong Wei, M.D.)
    Contact: Principal Investigator (Shihong Wei, M.D.)
  • Jiangmen Central Hospital, Jiangmen, Guangdong, China

    Contact: Study coordinator (Gengsheng Yu, M.D.)
    Contact: Principal Investigator (Gengsheng Yu, M.D.)
  • Liuzhou People's Hospital, Liuzhou, Guangxi, China

    Contact: Study coordinator (Leili Wang, M.D.)
    Contact: Principal Investigator (Leili Wang, M.D.)
  • Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Contact: Study coordinator (Jiangqiong Huang, M.D.)
    Contact: Principal Investigator (Jiangqiong Huang, M.D.)
  • The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

    Contact: Study coordinator (Qing Bu, M.D.)
    Contact: Principal Investigator (Qing Bu, M.D.)
  • Guangdong Provincial People's Hospital, Guangzhou, Guangzhou, China

    Contact: Study coordinator (Jing Li, M.D.)
    Contact: Principal Investigator (Jing Li, M.D.)
  • Guizhou Provincial People's Hospital, Guiyang, Guizhou, China

    Contact: Study coordinator (Yu Zhang, M.D.)
    Contact: Principal Investigator (Yu Zhang, M.D.)
  • The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China

    Contact: Study coordinator (Shiyun Xing, M.D.)
    Contact: Principal Investigator (Shiyun Xing, M.D.)
  • The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

    Contact: Study coordinator (Jun Wang, M.D.)
    Contact: Principal Investigator (Jun Wang, M.D.)
  • Tangshan People's Hospital, Tangshan, Hebei, China

    Contact: Study coordinator (Zhiwu Wang, M.D.)
    Contact: Principal Investigator (Zhiwu Wang, M.D.)
    Contact: Principal Investigator (Guilan Dong, M.D.)
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

    Contact: Study coordinator (Yan Yu, M.D.)
    Contact: Principal Investigator (Yan Yu, M.D.)
  • The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

    Contact: Study coordinator (Yu Yang, M.D.)
    Contact: Principal Investigator (Yu Yang, M.D.)
  • Anyang Cancer Hospital, Anyang, Henan, China

    Contact: Study coordinator (Anping Zheng, M.D.)
    Contact: Principal Investigator (Anping Zheng, M.D.)
  • The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China

    Contact: Study coordinator (Qingqin Zhang, M.D.)
    Contact: Principal Investigator (Qingqin Zhang, M.D.)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Yanqiu Zhao, M.D.)
    Contact: Principal Investigator (Yanqiu Zhao, M.D.)
  • Jingzhou First People's Hospital, Jingzhou, Hubei, China

    Contact: Study coordinator (Yonghua Yang, M.D.)
    Contact: Principal Investigator (Yonghua Yang, M.D.)
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Xiaorong Dong, M.D.)
    Contact: Principal Investigator (Xiaorong Dong, M.D.)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Yongzhong Luo, M.D.)
    Contact: Principal Investigator (Yongzhong Luo, M.D.)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Lin Wu, M.D.)
    Contact: Principal Investigator (Lin Wu, M.D.)
    Contact: Principal Investigator (Huai Liu, M.D.)
  • The First Affiliated Hospital of South China University, Hengyang, Hunan, China

    Contact: Study coordinator (Yuehua Li, M.D.)
    Contact: Principal Investigator (Yuehua Li, M.D.)
  • General Hospital of the PLA Eastern Theater Command, Nanjing, Jiangsu, China

    Contact: Study coordinator (Xiangfeng Lv, M.D.)
    Contact: Principal Investigator (Xiangfeng Lv, M.D.)
  • Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

    Contact: Study coordinator (Lin Shi, M.D.)
    Contact: Principal Investigator (Lin Shi, M.D.)
  • Xuzhou Municipal Hospital, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Haitao Yin, M.D.)
    Contact: Principal Investigator (Haitao Yin, M.D.)
  • The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China

    Contact: Study coordinator (Jie Li, M.D.)
    Contact: Principal Investigator (Jie Li, M.D.)
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Longhua Sun, M.D.)
    Contact: Principal Investigator (Longhua Sun, M.D.)
  • Jilin Cancer Hospital, Changchun, Jilin, China

    Contact: Study coordinator (Haifeng Liu, M.D.)
    Contact: Principal Investigator (Haifeng Liu, M.D.)
  • The First Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Bo Jin, M.D.)
    Contact: Principal Investigator (Bo Jin, M.D.)
  • Ningxia Medical University General Hospital, Yinchuan, Ningxia, China

    Contact: Study coordinator (Yanyang Wang, M.D.)
    Contact: Principal Investigator (Yanyang Wang, M.D.)
  • Shandong Provincial Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Zhe Yang, M.D.)
    Contact: Principal Investigator (Zhe Yang, M.D.)
  • Shandong Cancer Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Hui Zhu, M.D.)
    Contact: Principal Investigator (Hui Zhu, M.D.)
  • Linyi Cancer Hospital, Linyi, Shandong, China

    Contact: Study coordinator (Jianhua Shi, M.D.)
    Contact: Principal Investigator (Jianhua Shi, M.D.)
  • Linyi People's Hospital, Linyi, Shandong, China

    Contact: Study coordinator (Zhongmin Zhang, M.D.)
    Xueliang Xu, M.D. (Sub-investigator)
    Contact: Principal Investigator (Zhongmin Zhang, M.D.)
  • Qingdao Central Hospital of Health and Rehabilitation Sciences University, Qingdao, Shandong, China

    Contact: Study coordinator (Zhen Zhang, M.D.)
    Contact: Study coordinator (Xiaotao Zhang, M.D.)
    Contact: Principal Investigator (Zhen Zhang, M.D.)
    Contact: Principal Investigator (Xiaotao Zhang, M.D.)
  • Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China

    Contact: Study coordinator (Shifeng Kan, M.D.)
    Contact: Principal Investigator (Shifeng Kan, M.D.)
  • Weifang No.2 People's Hospital, Weifang, Shangdong, China

    Contact: Study coordinator (Kunning Yang, M.D.)
    Contact: Principal Investigator (Kunning Yang, M.D.)
  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Zhengfei Zhu, M.D.)
    Contact: Principal Investigator (Zhengfei Zhu, M.D.)
  • Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Fengying Wu, M.D.)
    Contact: Principal Investigator (Fengying Wu, M.D.)
  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Hongwei Li, M.D.)
    Contact: Principal Investigator (Hongwei Li, M.D.)
  • Tangdu Hospital, The Fourth Military Medical University, Xi’an, Shanxi, China

    Contact: Study coordinator (Xiaolong Yan, M.D.)
    Contact: Principal Investigator (Xiaolong Yan, M.D.)
  • Mianyang Central Hospital, Mianyang, Sichuan, China

    Contact: Study coordinator (Xiaobo Du, M.D.)
    Contact: Principal Investigator (Xiaobo Du, M.D.)
  • Tianjin Cancer Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Dingzhi Huang, M.D.)
    Contact: Principal Investigator (Dingzhi Huang, M.D.)
  • The First Affiliated Hospital of Xi'an Jiaotong University, Shaxi, Xi'an, China

    Contact: Study coordinator (Yu Yao, M.D.)
    Contact: Principal Investigator (Yu Yao, M.D.)
  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

    Contact: Study coordinator (Yuping Li, M.D.)
    Contact: Principal Investigator (Yuping Li, M.D.)